Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Liquidia Technologies undertakes Phase 3 Clinical Trial of LIQ861 for Diagnosing PAH

Read more

PPD appoints Colin Hill to its Board of Directors

Read more

Symbiotix Biotherapies declares agreement with Paragon Bioservices for Process Development & Manufacturing

Read more

CIRCULOGENE’s Molecular Genetics Testing Ventures Into International Licensing Agreement With Turkey-Based Circulogene Saglik

Read more

U.S Subsidiary of CanniMed Therapeutics bids for State of Michigan License to Produce and Process Medical Cannabis

Read more

Glaukos submits IDE application to FDA seeking to examine iStent Infinite Trabecular Micro-Bypass System

Read more

ANI Pharmaceuticals acquires four NDAs from AstraZeneca for $46.5 Million

Read more

I-Mab Biopharma signs licensing agreement for HyLeukin with Genexine

Read more

Mallinckrodt to acquire Sucampo Pharmaceuticals for approximately $1.2 Billion

Read more

Teva Announces Exclusive Launch of a Generic Version of Reyataz in the U.S.

Read more

Posts pagination

Previous Page 1 of 923 … Page 819 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version